Journal of Nuclear Cardiology

, Volume 8, Issue 2, pp 171–181

Development and validation of a novel technique for murine first-pass radionuclide angiography with a fast multiwire camera and tantalum 178

  • Jeffrey L. Lacy
  • Tamanna Nanavaty
  • Dayang Dai
  • Nisha Nayak
  • Neal Haynes
  • Christopher Martin
Article

Abstract

Background

The use of genetically altered mice as a model system to study cardiovascular disease has created a need for accurate and quantitative assessment of murine ventricular function. To address this very challenging problem, we have developed a technique of murine firstpass radionuclide angiography using pinhole imaging and the short-lived isotope tantalum 178 (Ta-178) with a high-speed multiwire proportional camera (MPC).

Methods and Results

An MPC was fitted with a pinhole lens of 2-mm-diameter aperture positioned 15 cm from the camera face. The short-lived isotope Ta-178 (half-life 9.3 minutes) was generated from the tungsten 178 (W-178) (half-life 21.7 days)/Ta-178 generator and concentrated on site to an injection volume of 15 to 20 µL. Mice were imaged in the supine position with the chest wall 3 mm from the camera pinhole aperture, and images were acquired at 160 frames per second after a rapid bolus injection of Ta-178. In the absence of a true gold standard, the technology was validated with measurements in control mice and mice with surgically ligated left anterior descending arteries (LADs). In addition, the effects of pharmacologic intervention with verapamil and with dobutamine were observed. Finally, peak aortic velocity measurements obtained with this technology were compared with those obtained with echocardiographic Doppler ultrasonography, the only available quantitative comparator. There was a significant decrease in the mean left ventricular ejection fraction (LVEF) between normal mice (62% ± 4.6% [mean ± SEM], n = 12) and mice with experimentally induced myocardial infarction produced by surgical LAD ligation (22% ± 2.0%, n = 41; P <.01). The LVEF decreased from 51% ± 5.8% to 37% ± 3.5% in a group of normal mice receiving verapamil (P <.05, n = 8) and increased from 34% ± 2.2% to 43% ± 2.3% in a group of LAD-ligated mice receiving dobutamine (P <.01, n = 48). Peak camera sensitivity during first pass was 25,000 cps/mCi injected. Intraobserver and interobserver variability of LVEF was studied, yielding r = 0.9639 and 0.9529 and SE of the estimate 2.6% and 3.1%, respectively. Reproducibility in serial studies was excellent (r = 0.92, SE of the estimate 5.18).

Conclusions

This study demonstrates the development and use of a promising new method that uses the short-lived radioisotope Ta-178 and MPC for noninvasive quantification of murine ventricular function, that produces accurate and highly reproducible results, and that can be applied in multiple serial studies.

Key Words

First pass radionuclide angiography murine imaging tantalum 178 left ventricular ejection fraction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    James JF, Hewett TE, Robbins J. Cardiac physiology in transgenic mice. Circ Res 1998;82:407–15.PubMedGoogle Scholar
  2. 2.
    Kadambi VJ, Kranias EG. Genetically engineered mice: model systems for left ventricular failure. J Card Fail 1998;4:349–61.PubMedCrossRefGoogle Scholar
  3. 3.
    Izumo S, Shioi T. Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: a problem of (new) riches. J Card Fail 1998;4:263–70.PubMedCrossRefGoogle Scholar
  4. 4.
    Arbeit JM, Hirose R. Murine mentors: transgenic and knockout models of surgical disease. Ann Surg 1999;229:21–40.PubMedCrossRefGoogle Scholar
  5. 5.
    Carmeliet P, Moons L, Collen D. Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis. Cardiovasc Res 1998; 39:8–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee MA, Bohm M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 1996;270:E919–29.Google Scholar
  7. 7.
    Paigen B, Plump AS, Rubin EM. The mouse as a model for human cardiovascular disease and hyperlipidemia 1994;5:258–64.Google Scholar
  8. 8.
    French BA. Gene transfer and cardiovascular disorders. Herz 1993;18: 222–9.PubMedGoogle Scholar
  9. 9.
    Murakami K, Fukamizu A. Transgenic and knockout models in reninangiotensin system. Immunopharmacology 1999;44:1–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Verdouw PD, van den Doel MA, de Zeeuw S, Duncker DJ. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 1998;39:121–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Drago JPA, Accili D, Eisner GM, Felder RA. Transgenic mice to study the role of dopamine receptor in cardiovascular function. Clin Exp Hypertens 1997;19:15–25.PubMedCrossRefGoogle Scholar
  12. 12.
    Young SG. Using genetically modified mice to study apolipoprotein B. J Atheroscler Thromb 1996;3:62–74.PubMedGoogle Scholar
  13. 13.
    Penninger LP, Aitken K, Sole M, Mak T. The role of transgenic knockout models in defining the pathogenesis of viral heart disease. Eur Heart J 1995;16:25–7.PubMedGoogle Scholar
  14. 14.
    Waldenstrom A, Langstrom B. Assessment of cardiac metabolic disorders with positron emission tomography. Curr Opin Cardiol 1991;6: 965–71.PubMedGoogle Scholar
  15. 15.
    Garlick PB, Marsden PK, Cave AC, Parkes HG, Slates R, Shao Y. PET and NMR dual acquisition (PANDA): application to isolated, perfused rat hearts. NMR Biomed 1997;10:138–42.PubMedCrossRefGoogle Scholar
  16. 16.
    Shimada K, Yoshida K, Tadokoro H, Kitsukawa S, Takami A, Susuki K. High-resolution cardiac PET in rabbits: imaging and quantitation of myocardial blood flow. J Nucl Med 1998;39:2022–7.PubMedGoogle Scholar
  17. 17.
    Yoshida S, Dodd SJ, del Nido PJ, Williams DS, Ho C. Cardiac function of transplanted rat hearts using a working heart model assessed by magnetic resonance imaging. J Heart Lung Transplant 1999;18:1054–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Franco F, Dubois SK, Peshock RM, Shohet RV. Magnetic resonance imaging accurately estimates LV mass in transgenic mouse model of cardiac hypertrophy. Am J Physiol 1998;274:H679–83.Google Scholar
  19. 19.
    Franco F, Thomas GD, Giroir B, Bryant D, Bullock MC, Chwialkowski MC, et al. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1999;99:448–54.PubMedGoogle Scholar
  20. 20.
    Mor-Avi V, Korcarz C, Fentzke RC, Lin H, Leiden JM, Lang RM. Quantitative evaluation of left ventricular function in a transgenic mouse model of dilated cardiomyopathy with 2-dimensional contrast echocardiography. J Am Soc Echocardiogr 1999;12:209–14.PubMedCrossRefGoogle Scholar
  21. 21.
    Williams RV, Lorenz JN, Witt SA, Hellard DT, Khoury PR, Kimball TR. End-systolic stress-velocity and pressure dimension relationships by transthoracic echocardiography. Am J Physiol 1998;274:H1828–35.Google Scholar
  22. 22.
    Manning WJ, Wei JY, Katz SE, Douglas PS, Gwathmey JK. Echocardiographically detected myocardial infarction in the mouse. Lab Anim Sci 1993;43:583–5.PubMedGoogle Scholar
  23. 23.
    Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, et al. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A 1994;91:2694–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Rivers BJ. Diagnostic imaging strategies in small animal nephrology. Vet Clin North Am Small Anim Pract 1996;26:1505–17.PubMedGoogle Scholar
  25. 25.
    Hume SP, Jones T. Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation. Nucl Med Biol 1998;25:729–32.PubMedCrossRefGoogle Scholar
  26. 26.
    Weber DA, Ivanovic M. Ultra-high-resolution imaging of small ani- mals: implications for preclinical and research studies. J Nucl Cardiol 1999;6:332–44.PubMedCrossRefGoogle Scholar
  27. 27.
    Daniel GB, Mitchell SK, Mawby D, Sackman JE, Schmidt D. Renal nuclear medicine: a review. Vet Radiol Ultrasound 1999;40:572–87.PubMedCrossRefGoogle Scholar
  28. 28.
    Shevelev IA, Tsicalov EN, Gorbach AM, Budko KP, Sharaev GA. Thermoimaging of the brain. J Neurosci Methods 1993;46:49–57.PubMedCrossRefGoogle Scholar
  29. 29.
    Wolf GL. Technical improvements in the staging of cancer: the role of imaging and contrast agents. Artif Cells Blood Substit Immobil Biotechnol 1994;22:285–94PubMedCrossRefGoogle Scholar
  30. 30.
    Bischof DA, Delaloye B. Tumor imaging with monoclonal antibodies. Semin Nucl Med 1995;25:144–64.CrossRefGoogle Scholar
  31. 31.
    Chatziioannou AF, Cherry SR, Shao Y, Silverman R, Meadors K, Farquhar TH. Performance evaluation of microPET: a high-resolution lutetium, oxyorthosilicate PET scanner for animal imaging. J Nucl Med 1999;40:1164–75.PubMedGoogle Scholar
  32. 32.
    Jeavons AP, Chandler RA, Dettmar CAR. A 3D HIDAC-PET camera with sub-millimeter resolution for imaging small animals. IEEE Trans Nucl Sci 1999;46:468–73.CrossRefGoogle Scholar
  33. 33.
    Moor JV, Waller ML, Zhao S, Dodd NJF, Acton PD, Jeavons AP, et al. Feasibility of imaging photodynamics injury to tumors by high-resolution positron emission tomography. Eur J Nucl Med 1998;25: 1248–54.CrossRefGoogle Scholar
  34. 34.
    MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 1999; 6:785–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Moo AH, Cherry SR, Pollack DB, Hovada DA, Phelps ME. Application of positron emission tomography to determine cerebral glucose utilization in conscious infant monkeys. J Neurosci Methods 1999;88:123–33.CrossRefGoogle Scholar
  36. 36.
    Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, et al. Imaging adenoviral-directed gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A 1999;96:2333–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Cutler PD, Cherry SR, Hoffman EJ, Digby WM, Phelps ME. Design features and performance of a PET system for animal research. J Nucl Med 1992;33:595–604.PubMedGoogle Scholar
  38. 38.
    Cherry SR, Shao Y, Siegel S. Optical fiber readout of scintillator arrays using a multi-channel PMT: a high resolution PET detector for animal imaging. IEEE Trans Nucl Sci 1996;43:1932–7.CrossRefGoogle Scholar
  39. 39.
    Cherry SR, Chatziioannou A, Shao Y, Silverman RW, Meadors K, Phelps M. Brain imaging in small animals using MicroPET. In: Carson R, Daube-Witherspoon M, Herscovitch P, editors. Quantitative functional brain imaging with positron emission tomography. San Diego (CA): Academic Press; 1998. p. 3–9.Google Scholar
  40. 40.
    Qi J, Leahy R, Cherry S, Chatziioannou A, Farquhar T. High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol 1998;43:1001–13.PubMedCrossRefGoogle Scholar
  41. 41.
    Carrig CB. Diagnostic imaging of osteoarthritis. Vet Clin North Am Small Anim Pract 1997;27:777–814.PubMedGoogle Scholar
  42. 42.
    Li KC. MR angiography of abdominal ischemia. Semin Ultrasound CT MR 1996;17:352–9.PubMedCrossRefGoogle Scholar
  43. 43.
    LeBlanc AD, Lacy JL, Johnson PC, Poliner LR, Jhingran SG. Tantalum-178 count-rate limitations of Anger and multicrystal cameras Radiology 1983;146:242–3.PubMedGoogle Scholar
  44. 44.
    Lacy JL, Verani MS, Ball ME, Boyce TM, Gibson RW, Roberts R. First-pass radionuclide angiography using a multiwire gamma camera and tantalum-178. J Nucl Med 1988;29:293–301.PubMedGoogle Scholar
  45. 45.
    Lacy JL, LeBlanc AD, Babich JW, Bungo MW, Laston LA, Lewis RM, et al. A gamma camera for medical applications, using a multiwire proportional counter. J Nucl Med 1984;256:1003–12.Google Scholar
  46. 46.
    Adams R, Lacy JL, Ball ME, Martin LJ. The count rate performance of a multiwire gamma camera measured by a decaying source method with 9.3-minute tantalum-178. J Nucl Med 1990;31:1723–6.PubMedGoogle Scholar
  47. 47.
    Ott RJ. Wire chambers revisited. Eur J Nucl Med 1993;20:348–58.PubMedCrossRefGoogle Scholar
  48. 48.
    Verani M, Guidry G, Mahmarian J, Shigeyuki N, Theodoros A, Roberts R, et al. Effects of acute, transient coronary occlusion on global and regional right ventricular function in humans. J Am Coll Cardiol 1992;20:1490–7.PubMedGoogle Scholar
  49. 49.
    Gioia G, Lin B, Katz R, Dimarino AJ, Ogilby JD, Cassel D, et al. Use of tantalum-178 generator and a multiwire gamma camera to study the effect of the Mueller maneuver on left ventricular performance: comparison to hemodynamics and single photon emission computed tomography perfusion patterns. Am Heart J 1995;130:1062–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Ott RJ, Flower MA, Babich JW, Marsden PK. The physics of radioisotope imaging. In: Webb S, editor. The physics of medical imaging. London: Institute of Physics Publishing; 1988. p. 171–5.Google Scholar
  51. 51.
    Iskandrian AS, Verani MS. First-pass radionuclide angiography with a multiwire gamma camera. In: Iskandrian AS, Verani MS, editors. New developments in cardiac nuclear imaging. Armonk (NY): Futura Publishing; 1998. p. 79–93.Google Scholar
  52. 52.
    Iskandrian AS, Verani MS. Nuclear cardiac imaging: principles and applications. Philadelphia: FA Davis; 1996.Google Scholar
  53. 53.
    Hartley CJ, Lacy JL, Dai D, Nayak N, Taffet GE, Entman ML, et al. Functional cardiac imaging in mice using Ta-178. Nature Med 1999;5:237–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Lacy J, Ball ME, Verani M, Wiles HB, Babich JW, LeBlanc AD, et al. An improved tungsten-178/tantalum-178 generator system for high volume clinical application. J Nucl Med 1988;29:1526–38.PubMedGoogle Scholar
  55. 55.
    Lacy JL, Layne WW, Guidry G, Verani M, Roberts R. Development and clinical performance of automated, portable tungsten-178/tantalum- 178 generator. J Nucl Med 1991;32:2158–61.PubMedGoogle Scholar
  56. 56.
    Verani MS, Lacy J, Guidry GW, Nishimura S, Mahmarian JJ, Athanasoulis T, et al. Quantification of left ventricular performance during transient coronary occlusion at various anatomic sites in humans: a study using tantalum-178 and a multiwire gamma camera. J Am Coll Cardiol 1992;19:297–306.PubMedCrossRefGoogle Scholar
  57. 57.
    National Institutes of Health Office of Science and Health Reports. DHHS Publication No. 85-23. Guide for the care and use of laboratory animals. Washington DC: National Academy Press; 1985.Google Scholar
  58. 58.
    Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, et al. Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol 1999;277:H660–8.Google Scholar
  59. 59.
    Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, et al. Myocardial ischemia and reperfusion: a murine model. Am J Physiol 1995;269:H2147–54.Google Scholar
  60. 60.
    Hartley CJ, Michael LH, Entman ML. Noninvasive measurement of ascending aortic blood velocity in mice. Am J Physiol 1999;268(1 Pt 2):H499–505.Google Scholar
  61. 61.
    Scherrer-Crosbie M, Steudel W, Hunziker PR, Liel-Cohen N, Ullrich WM, Picard MH. Three-dimensional echocardiographic assessment of left ventricular wall motion abnormalities in mouse myocardial infarction. J Am Soc Echocardiogr 1999;12:834–40.PubMedCrossRefGoogle Scholar
  62. 62.
    Ruff J, Wiesmann F, Hiller K, Voll S, Kienlin M, Bauer WR, et al. Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med 1998;40:43–8PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2001

Authors and Affiliations

  • Jeffrey L. Lacy
    • 1
  • Tamanna Nanavaty
    • 1
  • Dayang Dai
    • 1
  • Nisha Nayak
    • 1
  • Neal Haynes
    • 1
  • Christopher Martin
    • 1
  1. 1.Proportional Technologies, IncHouston

Personalised recommendations